State Rep. Ilhan Omar was endorsed for Congress by the Fifth District DFL on the second ballot, earning 68 percent of support. MinnPost’s journalists are out in the community to report on the things ...

DENVER — Every Republican-held Congressional seat in Colorado is up for grabs. Nine-term Republican Congressman Doug Lamborn announced on Friday morning that he is retiring. That opens up ...

Please provide your email address to receive an email when new articles are posted on . CD5 knockout CAR-T exhibited efficacy in several preclinical models. A phase 1 trial will evaluate the approach ...

PHILADELPHIA – The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a ...

The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on ...

PLEASANTON, Calif. & NANJING, China & SHANGHAI--(BUSINESS WIRE)--IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company advancing the development of novel cell therapies for ...

PHOENIX – Former Pinal County Sheriff Mark Lamb launched his campaign for Congress in strong position, according to a local pollster, but there’s a big X factor looming over the race. Mike Noble, ...

MB-105, a CD5-targeted CAR-T cell therapy, is being evaluated in a phase 2 trial for relapsed or refractory CD5-positive T-cell lymphoma. The trial, led by Dr. Swaminathan P. Iyer, will assess ...

Knocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology enhanced the engineered T cells' ability to eliminate blood cancers. Knocking out a protein ...

A phase 2 study to confirm safety and efficacy of MB-105, an autologous CD5-directed CAR T-cell therapy, in relapsed/refractory T-cell lymphoma (R/R TCL). This is an ASCO Meeting Abstract from the ...